We further demonstrated that plasma levels of CCL28 and IGFBP2 proteins were significantly higher in breast cancer patients during taxane-based chemotherapy than post-chemotherapy (Fig. S6G, Table S5). The gene discussed is CCL28; the disease is breast carcinoma.